Literature DB >> 17041768

[Functional gastrointestinal disorders].

Gabriele Moser1.   

Abstract

The functional gastrointestinal disorders (FGID) are the most frequent clinical conditions seen in practice. The FGID are associated with significant work absenteeism, impaired quality of life and increased medical costs. Most patients also suffer from psychosocial problems. Therefore it is important to define the patient's complaints in terms of a biopsychosocial disorder rather than just a medical illness. Physicians must acknowledge the relevance of the psychosocial aspects to prepare the patient for a referral to a specialist (in psychosomatic medicine or a psychotherapist) and to get the patient interested in the psychological factors involved as well as further explore their cause. Most of the research on psychotherapy in FGID to date has focused on the irritable bowel syndrome, and different methods of treatments have been studied (e. g., cognitive-behavioral therapy, dynamic psychotherapy, hypnotherapy, and relaxation). Randomised controlled studies have shown that psychotherapy is superior to conventional medical therapy. Hypnotherapy seems to be very successful. Predictors of a positive response to psychological treatment generally are: (1) awareness that stress exacerbates their bowel symptoms, (2) mild anxiety or depression, (3) the predominant bowel symptom is abdominal pain or diarrhea and not constipation, (4) the abdominal pain waxes and wanes in response to eating, defecation, or stress rather than being constant pain, and (5) the symptoms are of relatively short duration. Psychotherapy is initially relatively expensive because it requires multiple, long sessions. However, its benefits persist or even increase over time, and in the long run, there may be a reduction in clinic visits and health care costs which offsets the initial cost of psychological treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17041768     DOI: 10.1007/s10354-006-0323-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  28 in total

1.  Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome.

Authors:  R Lea; L A Houghton; E L Calvert; S Larder; W M Gonsalkorale; V Whelan; J Randles; P Cooper; P Cruickshanks; V Miller; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

Review 2.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  D A Drossman; F H Creed; K W Olden; J Svedlund; B B Toner; W E Whitehead
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Sexual and physical abuse in women with functional or organic gastrointestinal disorders.

Authors:  D A Drossman; J Leserman; G Nachman; Z M Li; H Gluck; T C Toomey; C M Mitchell
Journal:  Ann Intern Med       Date:  1990-12-01       Impact factor: 25.391

4.  Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility.

Authors:  M Delvaux; P Denis; H Allemand
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-04       Impact factor: 2.566

5.  Regional cerebral activity in normal and pathological perception of visceral pain.

Authors:  D H Silverman; J A Munakata; H Ennes; M A Mandelkern; C K Hoh; E A Mayer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

6.  The role of psychological and biological factors in postinfective gut dysfunction.

Authors:  K A Gwee; Y L Leong; C Graham; M W McKendrick; S M Collins; S J Walters; J E Underwood; N W Read
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

7.  Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

Authors:  R B Lydiard; M D Fossey; W Marsh; J C Ballenger
Journal:  Psychosomatics       Date:  1993 May-Jun       Impact factor: 2.386

8.  The irritable bowel syndrome: long-term prognosis and the physician-patient interaction.

Authors:  D M Owens; D K Nelson; N J Talley
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

9.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

10.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

View more
  1 in total

1.  Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers.

Authors:  Elsa M Eriksson; Kristina I Andrén; Henry T Eriksson; Göran K Kurlberg
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.